Fetuin-A in Metabolic syndrome: A systematic review and meta-analysis

Fetuin-A has been associated with the progression of metabolic syndrome, but previous studies found inconsistent results on the relationship between metabolic syndrome and the concentration of fetuin-A. The aim of this study was to perform a meta-analysis to summarize previous findings on this relat...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2020-03, Vol.15 (3), p.e0229776-e0229776
Main Authors: Pan, Xiongfeng, Wen, Shi Wu, Bestman, Prince L, Kaminga, Atipatsa C, Acheampong, Kwabena, Liu, Aizhong
Format: Article
Language:English
Subjects:
Analysis
Biological markers
Biology and Life Sciences
Biomarkers
Confidence intervals
Insulin resistance
Kinases
Medical research
Medicine and Health Sciences
Meta-analysis
Metabolic disorders
Metabolic syndrome
Novels
Physical Sciences
Research and Analysis Methods
Risk analysis
Risk factors
Studies
Tumor necrosis factor-TNF
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c692t-fdb145d12228b15708b8e4553d250fe9c87b82ec072f9ab7e7829ad55b52ce2d3
cites cdi_FETCH-LOGICAL-c692t-fdb145d12228b15708b8e4553d250fe9c87b82ec072f9ab7e7829ad55b52ce2d3
container_end_page e0229776
container_issue 3
container_start_page e0229776
container_title PloS one
container_volume 15
creator Pan, Xiongfeng
Wen, Shi Wu
Bestman, Prince L
Kaminga, Atipatsa C
Acheampong, Kwabena
Liu, Aizhong
description Fetuin-A has been associated with the progression of metabolic syndrome, but previous studies found inconsistent results on the relationship between metabolic syndrome and the concentration of fetuin-A. The aim of this study was to perform a meta-analysis to summarize previous findings on this relationship. This study was registered with the International Prospective Register of Systematic Reviews PROSPERO (CRD42019129566). Studies examining the relationship between metabolic syndrome and the concentration of circulating fetuin-A were identified using a systematic search in the electronic databases of Embase, PubMed, Web of Science, and Cochrane Library before March 2019. A random effects model was used to summarize the effect size of the association in terms of the standardized mean difference (SMD). Fourteen eligible studies compared fetuin-A concentrations between 4,551 metabolic syndrome patients and 8,805 controls. The circulating fetuin-A concentration was significantly higher in the metabolic syndrome patients than in the controls (SMD = 0.65, 95% confidence interval (CI): 0.48 to 0.83, Z = 7.18, p
doi_str_mv 10.1371/journal.pone.0229776
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2371812887</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A616409782</galeid><doaj_id>oai_doaj_org_article_f353a9febfde470a9239bf1f075c993c</doaj_id><sourcerecordid>A616409782</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-fdb145d12228b15708b8e4553d250fe9c87b82ec072f9ab7e7829ad55b52ce2d3</originalsourceid><addsrcrecordid>eNqNkktv1DAUhSMEog_4BwgiISFYZPAjjm0WSKOqhZGKKvHaWo5zPeNREk_jpGX-PZ5OWk1QF8iLWDffPfY9PknyCqMZphx_XPuha3U92_gWZogQyXnxJDnGkpKsIIg-PdgfJSchrBFiVBTF8-SIEkxzWcjj5PwC-sG12Tx1bfoNel362pk0bNuq8w18SudxH3podB_LHdw4uE11W6VNZDMdL7ANLrxInlldB3g5fk-TXxfnP8--ZpdXXxZn88vMFJL0ma1KnLMKE0JEiRlHohSQM0YrwpAFaQQvBQGDOLFSlxy4IFJXjJWMGCAVPU3e7HU3tQ9qdCAoEv0QmAjBI7HYE5XXa7XpXKO7rfLaqbuC75ZKd3GUGpSljGppobQV5BxpSagsLbaIMyMlNVHr83jaUDZQGWj7TtcT0emf1q3U0t8ojpigVEaB96NA568HCL1qXDBQ17oFP9zdO6eMS7FD3_6DPj7dSC11HMC11sdzzU5UzQtc5EhGxyI1e4SKq4LGmRgX62J90vBh0hCZHv70Sz2EoBY_vv8_e_V7yr47YFeg634VfD30zrdhCuZ70HQ-hA7sg8kYqV3a791Qu7SrMe2x7fXhAz003ceb_gWUFfkR</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2371812887</pqid></control><display><type>article</type><title>Fetuin-A in Metabolic syndrome: A systematic review and meta-analysis</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Pan, Xiongfeng ; Wen, Shi Wu ; Bestman, Prince L ; Kaminga, Atipatsa C ; Acheampong, Kwabena ; Liu, Aizhong</creator><contributor>Beiki, Omid</contributor><creatorcontrib>Pan, Xiongfeng ; Wen, Shi Wu ; Bestman, Prince L ; Kaminga, Atipatsa C ; Acheampong, Kwabena ; Liu, Aizhong ; Beiki, Omid</creatorcontrib><description>Fetuin-A has been associated with the progression of metabolic syndrome, but previous studies found inconsistent results on the relationship between metabolic syndrome and the concentration of fetuin-A. The aim of this study was to perform a meta-analysis to summarize previous findings on this relationship. This study was registered with the International Prospective Register of Systematic Reviews PROSPERO (CRD42019129566). Studies examining the relationship between metabolic syndrome and the concentration of circulating fetuin-A were identified using a systematic search in the electronic databases of Embase, PubMed, Web of Science, and Cochrane Library before March 2019. A random effects model was used to summarize the effect size of the association in terms of the standardized mean difference (SMD). Fourteen eligible studies compared fetuin-A concentrations between 4,551 metabolic syndrome patients and 8,805 controls. The circulating fetuin-A concentration was significantly higher in the metabolic syndrome patients than in the controls (SMD = 0.65, 95% confidence interval (CI): 0.48 to 0.83, Z = 7.18, p&lt;0.001). Besides, circulating fetuin-A was a risk factor for metabolic syndrome (odds ratio 1.23, 95% CI: 1.08 to 1.40). These findings suggest that fetuin-A may be an important indicator for metabolic syndrome, in which case this may lead to new perspectives in early diagnosis, identification of novel biomarkers, and providing novel targets for pharmacological interventions.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0229776</identifier><identifier>PMID: 32134969</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Analysis ; Biological markers ; Biology and Life Sciences ; Biomarkers ; Confidence intervals ; Insulin resistance ; Kinases ; Medical research ; Medicine and Health Sciences ; Meta-analysis ; Metabolic disorders ; Metabolic syndrome ; Novels ; Physical Sciences ; Research and Analysis Methods ; Risk analysis ; Risk factors ; Studies ; Tumor necrosis factor-TNF</subject><ispartof>PloS one, 2020-03, Vol.15 (3), p.e0229776-e0229776</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><rights>2020 Pan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Pan et al 2020 Pan et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-fdb145d12228b15708b8e4553d250fe9c87b82ec072f9ab7e7829ad55b52ce2d3</citedby><cites>FETCH-LOGICAL-c692t-fdb145d12228b15708b8e4553d250fe9c87b82ec072f9ab7e7829ad55b52ce2d3</cites><orcidid>0000-0001-6890-1583 ; 0000-0002-3443-6465</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2371812887/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2371812887?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32134969$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Beiki, Omid</contributor><creatorcontrib>Pan, Xiongfeng</creatorcontrib><creatorcontrib>Wen, Shi Wu</creatorcontrib><creatorcontrib>Bestman, Prince L</creatorcontrib><creatorcontrib>Kaminga, Atipatsa C</creatorcontrib><creatorcontrib>Acheampong, Kwabena</creatorcontrib><creatorcontrib>Liu, Aizhong</creatorcontrib><title>Fetuin-A in Metabolic syndrome: A systematic review and meta-analysis</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Fetuin-A has been associated with the progression of metabolic syndrome, but previous studies found inconsistent results on the relationship between metabolic syndrome and the concentration of fetuin-A. The aim of this study was to perform a meta-analysis to summarize previous findings on this relationship. This study was registered with the International Prospective Register of Systematic Reviews PROSPERO (CRD42019129566). Studies examining the relationship between metabolic syndrome and the concentration of circulating fetuin-A were identified using a systematic search in the electronic databases of Embase, PubMed, Web of Science, and Cochrane Library before March 2019. A random effects model was used to summarize the effect size of the association in terms of the standardized mean difference (SMD). Fourteen eligible studies compared fetuin-A concentrations between 4,551 metabolic syndrome patients and 8,805 controls. The circulating fetuin-A concentration was significantly higher in the metabolic syndrome patients than in the controls (SMD = 0.65, 95% confidence interval (CI): 0.48 to 0.83, Z = 7.18, p&lt;0.001). Besides, circulating fetuin-A was a risk factor for metabolic syndrome (odds ratio 1.23, 95% CI: 1.08 to 1.40). These findings suggest that fetuin-A may be an important indicator for metabolic syndrome, in which case this may lead to new perspectives in early diagnosis, identification of novel biomarkers, and providing novel targets for pharmacological interventions.</description><subject>Analysis</subject><subject>Biological markers</subject><subject>Biology and Life Sciences</subject><subject>Biomarkers</subject><subject>Confidence intervals</subject><subject>Insulin resistance</subject><subject>Kinases</subject><subject>Medical research</subject><subject>Medicine and Health Sciences</subject><subject>Meta-analysis</subject><subject>Metabolic disorders</subject><subject>Metabolic syndrome</subject><subject>Novels</subject><subject>Physical Sciences</subject><subject>Research and Analysis Methods</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Studies</subject><subject>Tumor necrosis factor-TNF</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkktv1DAUhSMEog_4BwgiISFYZPAjjm0WSKOqhZGKKvHaWo5zPeNREk_jpGX-PZ5OWk1QF8iLWDffPfY9PknyCqMZphx_XPuha3U92_gWZogQyXnxJDnGkpKsIIg-PdgfJSchrBFiVBTF8-SIEkxzWcjj5PwC-sG12Tx1bfoNel362pk0bNuq8w18SudxH3podB_LHdw4uE11W6VNZDMdL7ANLrxInlldB3g5fk-TXxfnP8--ZpdXXxZn88vMFJL0ma1KnLMKE0JEiRlHohSQM0YrwpAFaQQvBQGDOLFSlxy4IFJXjJWMGCAVPU3e7HU3tQ9qdCAoEv0QmAjBI7HYE5XXa7XpXKO7rfLaqbuC75ZKd3GUGpSljGppobQV5BxpSagsLbaIMyMlNVHr83jaUDZQGWj7TtcT0emf1q3U0t8ojpigVEaB96NA568HCL1qXDBQ17oFP9zdO6eMS7FD3_6DPj7dSC11HMC11sdzzU5UzQtc5EhGxyI1e4SKq4LGmRgX62J90vBh0hCZHv70Sz2EoBY_vv8_e_V7yr47YFeg634VfD30zrdhCuZ70HQ-hA7sg8kYqV3a791Qu7SrMe2x7fXhAz003ceb_gWUFfkR</recordid><startdate>20200305</startdate><enddate>20200305</enddate><creator>Pan, Xiongfeng</creator><creator>Wen, Shi Wu</creator><creator>Bestman, Prince L</creator><creator>Kaminga, Atipatsa C</creator><creator>Acheampong, Kwabena</creator><creator>Liu, Aizhong</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-6890-1583</orcidid><orcidid>https://orcid.org/0000-0002-3443-6465</orcidid></search><sort><creationdate>20200305</creationdate><title>Fetuin-A in Metabolic syndrome: A systematic review and meta-analysis</title><author>Pan, Xiongfeng ; Wen, Shi Wu ; Bestman, Prince L ; Kaminga, Atipatsa C ; Acheampong, Kwabena ; Liu, Aizhong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-fdb145d12228b15708b8e4553d250fe9c87b82ec072f9ab7e7829ad55b52ce2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Analysis</topic><topic>Biological markers</topic><topic>Biology and Life Sciences</topic><topic>Biomarkers</topic><topic>Confidence intervals</topic><topic>Insulin resistance</topic><topic>Kinases</topic><topic>Medical research</topic><topic>Medicine and Health Sciences</topic><topic>Meta-analysis</topic><topic>Metabolic disorders</topic><topic>Metabolic syndrome</topic><topic>Novels</topic><topic>Physical Sciences</topic><topic>Research and Analysis Methods</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Studies</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pan, Xiongfeng</creatorcontrib><creatorcontrib>Wen, Shi Wu</creatorcontrib><creatorcontrib>Bestman, Prince L</creatorcontrib><creatorcontrib>Kaminga, Atipatsa C</creatorcontrib><creatorcontrib>Acheampong, Kwabena</creatorcontrib><creatorcontrib>Liu, Aizhong</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medicine (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Database‎ (1962 - current)</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pan, Xiongfeng</au><au>Wen, Shi Wu</au><au>Bestman, Prince L</au><au>Kaminga, Atipatsa C</au><au>Acheampong, Kwabena</au><au>Liu, Aizhong</au><au>Beiki, Omid</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fetuin-A in Metabolic syndrome: A systematic review and meta-analysis</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2020-03-05</date><risdate>2020</risdate><volume>15</volume><issue>3</issue><spage>e0229776</spage><epage>e0229776</epage><pages>e0229776-e0229776</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Fetuin-A has been associated with the progression of metabolic syndrome, but previous studies found inconsistent results on the relationship between metabolic syndrome and the concentration of fetuin-A. The aim of this study was to perform a meta-analysis to summarize previous findings on this relationship. This study was registered with the International Prospective Register of Systematic Reviews PROSPERO (CRD42019129566). Studies examining the relationship between metabolic syndrome and the concentration of circulating fetuin-A were identified using a systematic search in the electronic databases of Embase, PubMed, Web of Science, and Cochrane Library before March 2019. A random effects model was used to summarize the effect size of the association in terms of the standardized mean difference (SMD). Fourteen eligible studies compared fetuin-A concentrations between 4,551 metabolic syndrome patients and 8,805 controls. The circulating fetuin-A concentration was significantly higher in the metabolic syndrome patients than in the controls (SMD = 0.65, 95% confidence interval (CI): 0.48 to 0.83, Z = 7.18, p&lt;0.001). Besides, circulating fetuin-A was a risk factor for metabolic syndrome (odds ratio 1.23, 95% CI: 1.08 to 1.40). These findings suggest that fetuin-A may be an important indicator for metabolic syndrome, in which case this may lead to new perspectives in early diagnosis, identification of novel biomarkers, and providing novel targets for pharmacological interventions.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>32134969</pmid><doi>10.1371/journal.pone.0229776</doi><tpages>e0229776</tpages><orcidid>https://orcid.org/0000-0001-6890-1583</orcidid><orcidid>https://orcid.org/0000-0002-3443-6465</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2020-03, Vol.15 (3), p.e0229776-e0229776
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2371812887
source Open Access: PubMed Central; Publicly Available Content Database
subjects Analysis
Biological markers
Biology and Life Sciences
Biomarkers
Confidence intervals
Insulin resistance
Kinases
Medical research
Medicine and Health Sciences
Meta-analysis
Metabolic disorders
Metabolic syndrome
Novels
Physical Sciences
Research and Analysis Methods
Risk analysis
Risk factors
Studies
Tumor necrosis factor-TNF
title Fetuin-A in Metabolic syndrome: A systematic review and meta-analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A25%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fetuin-A%20in%20Metabolic%20syndrome:%20A%20systematic%20review%20and%20meta-analysis&rft.jtitle=PloS%20one&rft.au=Pan,%20Xiongfeng&rft.date=2020-03-05&rft.volume=15&rft.issue=3&rft.spage=e0229776&rft.epage=e0229776&rft.pages=e0229776-e0229776&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0229776&rft_dat=%3Cgale_plos_%3EA616409782%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c692t-fdb145d12228b15708b8e4553d250fe9c87b82ec072f9ab7e7829ad55b52ce2d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2371812887&rft_id=info:pmid/32134969&rft_galeid=A616409782&rfr_iscdi=true